FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: coronary artery disease

Sort
E.g., 2013-05-25
E.g., 2013-05-25
Enter a comma separated list of user names.

Cardium CEO Discusses Generx, Excellagen and MedPodium with CEOCFOInterviews.com
Posted by OTC Showcase on July 16th, 2012

Read More
comment 0
Share
Tags:
cardiovascular disease, Cardium Therapeutics, Cell Therapy, chronic wound care, CXM, diabetic foot ulcers, diabetic ulcers, diabetic wounds, dna therapy, Excellagen, gene therapy, generx, regenerative medicine, stem cells, MedPodium, coronary artery disease

Cardium Therapeutics Presents at Marcum MicroCap Conference 2012 Video
Posted by OTC Showcase on July 13th, 2012

Christopher J. Reinhard, Chairman & CEO presented at the Marcum MicroCap Conference on June 20, 2012 at at the Roosevelt Hotel in New York City. In the presentation, Mr. Reinhard details Cardium products, including Generx as a product candidate for advanced coronary artery disease, Excellagen for wound care management and the company’s line of MedPodium neutraceuticals,metabolics and aesthetics.

Read More
comment 0
Share
Tags:
cardiovascular disease, Cardium Therapeutics, Cell Therapy, chronic wound care, CXM, diabetic foot ulcers, diabetic ulcers, diabetic wounds, dna therapy, Excellagen, gene therapy, generx, regenerative medicine, stem cells, MedPodium, coronary artery disease

SAVW, ASH, FSYS, STXS - DoubleInStocks.com Evening Stock Watch!
Posted by doubleinstocks1 on November 19th, 2010

SAVW is leading the LED lighting revolution and setting the stage to obsolete the incandescent light bulb through the use of energy-efficient, environmentally friendly LED lighting.

SAVW is a market-leading innovator of LED lighting.

** SAVW reported that their first product has been approved and received Lighting Facts® Certification by the U.S. Department of Energy.

Read More
comment 0
Share
Tags:
ASH, FSYS, NYSE:ASH, Fuel Systems Solutions, NASDAQ:FSYS, specialty chemicals, SAVW, SAVW.PK, SavWatt, Pink:SAVW, alternative fuel components, Ashland, cardiology instrument control, coronary artery disease, Nasdaq:STXS, Stereotaxis, STXS, sustainable solutions

ADVERTISE WITH US